Capstone Investment Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-116,200
Closed -$1.81M 1667
2020
Q3
$1.81M Buy
+116,200
New +$2M 0.01% 846
2019
Q4
Sell
-55,500
Closed -$1.21M 1385
2019
Q3
$1.21M Buy
55,500
+15,500
+39% +$355K 0.01% 873
2019
Q2
$1.01M Buy
+40,000
New +$950K 0.01% 946
2018
Q1
Sell
-49,300
Closed -$1.02M 358
2017
Q4
$1.02M Sell
49,300
-25,300
-34% -$401K 0.03% 194
2017
Q3
$1.07M Buy
74,600
+27,800
+59% +$420K 0.04% 209
2017
Q2
$808K Buy
+46,800
New +$561K 0.02% 349
2017
Q1
Sell
-107,500
Closed -$1.56M 875
2016
Q4
$1.56M Buy
107,500
+100,000
+1,333% +$1.83M 0.05% 330
2016
Q3
$184K Sell
7,500
-62,500
-89% -$1.62M ﹤0.01% 694
2016
Q2
$1.41M Buy
70,000
+24,000
+52% +$680K 0.03% 294
2016
Q1
$1.21M Buy
+46,000
New +$3.4M 0.04% 275
2014
Q3
Sell
-300
Closed -$37K 433
2014
Q2
$37K Buy
+300
New +$38.3K ﹤0.01% 391

Other funds holding BHC

Capstone Investment Advisors's BHC Position: Q1 2026 in Review

Capstone Investment Advisors reduced its Bausch Health (BHC) stake by 2.4% in Q1 2026, selling an estimated $13.5K and leaving 91,216 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Capstone Investment Advisors first reported a position in BHC in Q1 2014 and has held it in 19 quarters since. The position peaked at $2.64M in Q1 2014. 228 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Capstone Investment Advisors held 91,216 shares of Bausch Health worth $493K as of Q1 2026.
  • Capstone Investment Advisors sold 2,253 Bausch Health shares in Q1 2026, an estimated $13.5K.
  • Bausch Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1145 holding.
  • Capstone Investment Advisors first reported a position in Bausch Health in Q1 2014 and has held it in 19 quarters since.
  • Capstone Investment Advisors's Bausch Health position peaked at $2.64M in Q1 2014.
  • 228 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.